Sign in

Vijay G. Sankaran

@bloodgenes.bsky.social
3.5K followers 1.3K following 299 posts

Pediatric Hematologist/Oncologist, Geneticist, Stem Cell Biologist bloodgenes.org

PostsRepliesMedia
Reposted by Vijay G. Sankaran
Mick Milsom @milsommick.bsky.social · 04/10/2026
New publication from the groups of Duncan Odom, Marieke Essers and myself: Concentrating cell-type-specific transcriptional signatures in bone marrow from interspecies comparisons: Cell Genomics www.cell.com/cell-genomic... @dkfz.bsky.social
cell.com
Concentrating cell-type-specific transcriptional signatures in bone marrow from interspecies comparisons
The authors present a framework to isolate condensed marker gene signatures by requiring both conserved cell-type specificity and conserved expression across multi-species scRNA-seq datasets. Bone mar...
2152
Vijay G. Sankaran @bloodgenes.bsky.social · 30/09/2026
🩸🧬 Delighted to share our new @nature.com paper! Genetic studies of >28,000 people reveal a BACH2-NRF2 pathway for activating fetal hemoglobin, suggesting new tx avenues for sickle cell disease & β-thalassemia. Led by the amazing Chun-Jie Guo & co! www.nature.com/articles/s41...
nature.com
Human genetics implicates a BACH2–NRF2 axis in fetal haemoglobin activation - Nature
BACH2 restrains activation of the fetal-haemoglobin-encoding γ-globin genes, while loss of BACH2 enhances NRF2 chromatin occupancy and promotes the formation of activation foci at the γ-globin genes.
44312
Vijay G. Sankaran @bloodgenes.bsky.social · 07/08/2026
🚨Two complementary preprints from our group reveal convergent mechanisms of inherited B-ALL predisposition. Check out this terrific work led by @larawahlster.bsky.social, @alneehus.bsky.social & #AndrewLee! www.biorxiv.org/content/10.6... www.biorxiv.org/content/10.6...
1113
Reposted by Vijay G. Sankaran
Anders Sejr Hansen @andersshansen.bsky.social · 06/08/2026
(1/n) Excited to share close collab w @bloodgenes.bsky.social led by Varshini & Chun-jie et al How to induce expression of key genes while silencing much of the genome during Erythropoiesis? A: Matchmaker CREs load cohesin near key genes to promote looping & exp: www.biorxiv.org/content/10.6...
14714
Vijay G. Sankaran @bloodgenes.bsky.social · 06/08/2026
🚨👇 Check out this wonderful collaborative work identifying a new 3D genome regulator - Matchmakers - with the incredible @andersshansen.bsky.social ! Fantastic work led by Varshini Ramanathan and Chun-Jie Guo!
0104
Reposted by Vijay G. Sankaran
Silas Maniatis @manimota.bsky.social · 13/07/2026
Manhattanhenge Brooklyn golden hour remains undefeated
262
Reposted by Vijay G. Sankaran
Jayati Sharma, PhD, ScM @jayatirsharma.bsky.social · 07/07/2026
In what has been a labor of love & joyful collaboration, we are super excited to share our preprint on recommendations towards the ethical and accurate use of population descriptors generated from a survey by trainees, for trainees. www.biorxiv.org/content/10.6...
biorxiv.org
Recommendations for the ethical and accurate use of population descriptors: a trainee-led survey of early-career researchers
Despite the importance of population descriptors in human genomics research, many scientists struggle to translate evolving ethical guidelines into their computational workflows. To characterize this ...
12610
Reposted by Vijay G. Sankaran
John Doench @johndoench.bsky.social · 06/07/2026
New preprint from the group, comparing CRISPRko and CRISPRi via a Perturb-seq readout: www.biorxiv.org/content/10.6...
biorxiv.org
Direct comparison of CRISPR knockout and interference with Perturb-seq
CRISPR knockout (CRISPRko) and CRISPR interference (CRISPRi) are two workhorse technologies for loss-of-function studies, yet direct comparisons between the two are scant relative to their widespread ...
14117
Reposted by Vijay G. Sankaran
Elizabeth McKenna @elizsmckenna.bsky.social · 06/07/2026
Now online in Cancer Discovery @aacrjournals.bsky.social: Germline CDK12 Variants in Aggressive Prostate Cancer - by Sofie Tolmeijer, Colin Pritchard, Alexander Wyatt, and colleagues doi.org/10.1158/2159...
042
Reposted by Vijay G. Sankaran
Fusion Conferences @fusionconf.bsky.social · 30/06/2026
📅 Mark Your Calendars! The Hematologic Malignancies Conference is back for its second series! 🗓️ 01–04 November 2027 📍 Playa Mujeres, Mexico 🔔 Don't miss out! Sign up for updates and be the first to know when registration opens: bit.ly/4wiGXDJ
242
Vijay G. Sankaran @bloodgenes.bsky.social · 25/06/2026
🙏 Deeply honored to receive the 2026 Warren Alpert Prize! This award reflects the work by so many to enable transformative therapies for sickle cell disease and thalassemia, and the power of human genetics to reveal biology and guide new treatments! hms.harvard.edu/news/2026-wa...
hms.harvard.edu
2026 Warren Alpert Foundation Prize Awarded for Gene-Editing Therapies
Five scientists recognized for contributions to cures for sickle cell disease and beta-thalassemia
4313
Reposted by Vijay G. Sankaran
Anders Sejr Hansen @andersshansen.bsky.social · 22/06/2026
(1/n) Very excited to share tri-lab collab (Mirny & Zechner) led by Harvey, Henrik & Jack: Q: How do enhancers & promoters interact in space (contact vs. action-at-a-distance) and time (stable vs. transient)? A: Transient E-P contact (~25-42 nm lasting ~10-20 sec): www.biorxiv.org/content/10.6...
215277
Reposted by Vijay G. Sankaran
Prof Peter Hotez MD PhD DSc(hon) @peterhotezmdphd.bsky.social · 19/06/2026
www.usnews.com/news/live-ev...
usnews.com
22910
Vijay G. Sankaran @bloodgenes.bsky.social · 02/06/2026
🩸🧬 Dendritic cells are rare but key players in immunity. In a new preprint led by @ofircohn.bsky.social, we generate a single-cell multi-omic atlas of human dendritic cell differentiation to reveal links to immune-mediated disease: www.biorxiv.org/content/10.6...
0113
Reposted by Vijay G. Sankaran
Angelo D’Alessandro @dalessandrolab.bsky.social · 02/06/2026
Now out in Blood @ash.hematology.org @bloodjournals.hematology.org ashpublications.org/blood/articl... Really proud of this one, and grateful to the reviewers for the constructive criticism. It really is a much better paper now!
ashpublications.org
The red blood cell proteome and interactome identify a Band 3-BLVRB axis regulating hypoxic metabolic adaptation
Key Points. Deep proteomics defines a complete, contamination-free RBC proteome (3,775 proteins) and O2-dependent interactome by Xlinking proteomicsThe Ban
075
Reposted by Vijay G. Sankaran
Jonathan Pritchard @jkpritch.bsky.social · 01/06/2026
Combined Optical Pooled Screens and Perturb-seq! Great new work by Romain Lopez & Taka Kudo. This is one of a series of papers from our lab (here, with Aviv Regev) using perturbations to interpret human genetics; a key revelation for me is how transferable the mouse perturbs are to human genetics.
0266
Reposted by Vijay G. Sankaran
Adam Sperling, MD, PhD @adamssperling.bsky.social · 27/05/2026
Excited that our paper describing a phase 1 trial of ducabtagene autloeucel, a rapidly manufactured anti-BCMA CAR-T in r/r multiple myeloma, was published. #ScienceTranslationalMedicine Huge thanks to all my co-authors, the teams at @danafarber.bsky.social and Novartis, and to our patients.
science.org
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma
Durcabtagene autoleucel, a rapidly manufactured BCMA-directed CAR T cell therapy, was safe and efficacious in relapsed/refractory multiple myeloma.
2122
Vijay G. Sankaran @bloodgenes.bsky.social · 26/05/2026
I had such a wonderful time joining @stemcellpodcast for this conversation! It was a real pleasure to discuss how human genetics can illuminate 🩸 stem cell biology, hematopoiesis, and opportunities to develop better therapies. Thanks so much for having me!
0100
Reposted by Vijay G. Sankaran
Sternberg Lab @sternberglab.bsky.social · 21/05/2026
1/8 🚨 New preprint from the @sternberglab.bsky.social & @martinjinek.bsky.social labs! CRISPR-associated transposases (CASTs) insert large DNA cargoes at precise genomic locations — no double-strand breaks needed.
47928
Reposted by Vijay G. Sankaran
Molly Przeworski @mollyprz.bsky.social · 15/05/2026
Happy to highlight new findings by Vanesa Getseva and Lin Poyraz about the sources of variation in germline mutation rates among humans: www.biorxiv.org/content/10.6... Joint work with Anastasia Stolyarova and @ipsitaagarwal.bsky.social. 1/n
biorxiv.org
A sibling study of variation in parental mutation rates
People are born with variable numbers of de novo germline mutations (DNMs), depending primarily on the ages of their parents. To explore additional causes, we developed an approach to call DNMs from nucleotide differences between siblings in genomic regions inherited identical by descent from both parents. Applying it to whole genome sequences from 28,985 sibling pairs of diverse genetic ancestries present in the UK Biobank and All of Us datasets, as well as 2,330 trios, we identified >800K autosomal DNMs and characterized mutation phenotypes in 27,645 sets of parents. We found subtle shifts in the mutation spectrum but no differences in total DNM rates among genetic ancestry groups, or between smokers and non-smokers. Testing for associations between parental mutation phenotypes and their burden of loss-of-function and deleterious missense variants in a set of 180 DNA repair and maintenance genes, we discovered that disruptions in REV1 and LIG1 increase germline mutation rates, and thus that rare mutator alleles segregate in population cohorts. ### Competing Interest Statement The authors have declared no competing interest. NIH, R35 GM083098
16846
Vijay G. Sankaran @bloodgenes.bsky.social · 15/05/2026
Wonderful to spend time hiking with our incredible team! Grateful for this remarkable group and inspired every day by their creativity, dedication, kindness, and teamwork - both in and outside the lab. 🩸🧬
0100
Reposted by Vijay G. Sankaran
American Society of Pediatric Hematology/Oncology @aspho-hq.bsky.social · 02/05/2026
Thanks to all #ASPHO2026 attendees, speakers and presenters, Conference Chair #JessicaHeath, Vice Chair #CaitlinNeri and the Conference Planning Committee! See you in Montrẻal for #ASPHO2027 - Tuesday May 11 - Friday May 14!
011
Vijay G. Sankaran @bloodgenes.bsky.social · 02/05/2026
🙏 🙏 Really honored to receive the Oski Memorial Award and be able to participate in #ASPHO2026!! Thank you, @aspho-hq.bsky.social!
171
Vijay G. Sankaran @bloodgenes.bsky.social · 01/05/2026
🚨 Excited to share a new paper in Cell! Human genetics led us to HOTSCRAMBL, a HOXA-locus lncRNA that regulates 🩸#stemcell self-renewal and HOXA9 splicing, with implications for AML. Amazing work by @lvchosen1.bsky.social with many others! www.cell.com/cell/fulltex...
16121
Reposted by Vijay G. Sankaran
Karolin Luger @nucleosomepolice.bsky.social · 28/04/2026
New work from Sashi Weerawarana on how TFAM compacts mitochondrial DNA 🧬 TFAM oligomerizes on DNA to form compact, homogeneous higher-order complexes (see beautiful mass photometry data below), that still retain dynamic behavior. Congratulations Sashi and Wei. www.biorxiv.org/content/10.6...
56023
Reposted by Vijay G. Sankaran
Eric Topol @erictopol.bsky.social · 16/04/2026
Genome editing of blood stem cells to make therapeutic antibodies on demand! + applications for programming a factory of other proteins New @science.org science.org/doi/10.1126/... science.org/doi/10.1126/...
010623
Reposted by Vijay G. Sankaran
Richard Sever @richardsever.bsky.social · 10/04/2026
Saddened to learn of the death of Greg Hannon, a former CSHL colleague and giant of modern molecular biology www.cruk.cam.ac.uk/news/in-memo...
cruk.cam.ac.uk
In Memoriam: Professor Greg Hannon (1964–2026) - Cancer Research UK Cambridge Institute
Greg was already a world-renowned scientist when appointed Director, and for the community, he was a visionary leader, a cherished mentor, and a singular force of nature whose influence shaped the research landscape.
1397
Reposted by Vijay G. Sankaran
Ran Blekhman @blekhman.bsky.social · 05/04/2026
I wrote about why every lab should have AI use guidelines, and how to do it. open.substack.com/pub/blekhman...
open.substack.com
You need to make AI guidelines for your lab
Here's why you should, and how to start
318258
Reposted by Vijay G. Sankaran
Juan C. Landoni @jclandoni.bsky.social · 03/04/2026
Our paper is now out in Science! Super excited to share our discovery that #mitochondria #pearling is the elusive mechanism driving the regular distribution and inheritance of #mtDNA nucleoids 🧬 [1/6]
317665
Vijay G. Sankaran @bloodgenes.bsky.social · 01/04/2026
www.fondazionetelethon.it/en/stories-a...
fondazionetelethon.it
In memory of Claudio Bordignon, pioneer of gene therapy - Telethon
His work combined scientific vision, experimental rigor and a constant focus on the potential impact of research for patients affected by severe inherited diseases.
061
Vijay G. Sankaran @bloodgenes.bsky.social · 30/03/2026
❓A one-time, durable, and even reversible way to prevent thrombosis? In this preprint, led by @lrbzldz.bsky.social, we show that epigenome editing of 🩸 #StemCells can durably reprogram platelet function: www.biorxiv.org/content/10.6...
1165
Vijay G. Sankaran @bloodgenes.bsky.social · 24/03/2026
Amazing group!!! Congratulations!!! 👏👏👏
011
Vijay G. Sankaran @bloodgenes.bsky.social · 24/03/2026
Amazing documentary on cystic fibrosis 🫁 and Michael Welsh’s extraordinary contributions to therapies that have transformed so many lives: www.youtube.com/watch?v=PIXC...
youtube.com
Giving Back Breath: How an Iowa doctor led a breakthrough cystic fibrosis treatment
YouTube video by DMRegister
050
Reposted by Vijay G. Sankaran
Eric Topol @erictopol.bsky.social · 23/03/2026
Our thymus gland, neglected and assumed to be non-functional in adults, is taking center stage for healthy aging. Two new landmark studies erictopol.substack.com/p/your-thymu...
erictopol.substack.com
Your Thymus and Your Healthspan
New landmark studies using AI to determine thymus health and its link to major outcomes
111922
Vijay G. Sankaran @bloodgenes.bsky.social · 23/03/2026
🚨🧬🩸 Delighted to have this @naturerevgenet.bsky.social review w/ Michael Poeschla published today - Genetic Influences on #hematopoiesis: rdcu.be/e9vlD
rdcu.be
Genetic influences on haematopoiesis
Nature Reviews Genetics - Haematopoiesis is a classic process for understanding the genetic basis of human health and disease. In this Review, Poeschla and Sankaran discuss this history and more...
1184
Vijay G. Sankaran @bloodgenes.bsky.social · 19/03/2026
Incredibly fortunate to work with this amazing team and to learn from them every day!! @hhmi-science.bsky.social @bostonchildrens.bsky.social @danafarber.bsky.social @broadinstitute.org
0191
Reposted by Vijay G. Sankaran
Eric Topol @erictopol.bsky.social · 15/03/2026
erictopol.substack.com/p/the-missin... A biomarker you might want to know about
erictopol.substack.com
The Missing CHIP
Ignoring a very informative lab test
110430
Vijay G. Sankaran @bloodgenes.bsky.social · 16/03/2026
Great to see a complementary screen from the @fda.gov identify #ferroptosis inhibition as critical for expanding human 🩸 #stemcells in @moltherapy.bsky.social: www.cell.com/molecular-th... Nicely supports our prior findings: www.nature.com/articles/s41...
041
Reposted by Vijay G. Sankaran
James Olzmann @olzmannlab.bsky.social · 13/03/2026
1/3 Thrilled to see our paper led by Kirandeep Deol is out in Nature Structural & Molecular Biology! CRISPR screens to uncover a role for vitamin B2 metabolism in stabilizing FSP1 via FAD, revealing a new way vitamins regulate ferroptosis. www.nature.com/articles/s41...
nature.com
Vitamin B2 metabolism promotes FSP1 stability to prevent ferroptosis - Nature Structural & Molecular Biology
Here, Deol et al. use genetic screens in gene-edited reporter cell lines to identify regulators of ferroptosis suppressor protein 1 (FSP1) expression and stability. They show that vitamin B2 metabolis...
26015
Reposted by Vijay G. Sankaran
Pedro Friedmann Angeli @angelifriedmann.bsky.social · 13/03/2026
Happy to share the final version of the study where we describe a central role for vitaminB2 in regulating membrane redox state - some new cool experiments were added since the preprint was posted - pls check this out thttps://www.nature.com/articles/s41556-025-01856-x
nature.com
Riboflavin metabolism shapes FSP1-driven ferroptosis resistance - Nature Cell Biology
After performing a focused CRISPR–Cas9 screen, Skafar et al. identify riboflavin (vitamin B2) as a regulator of FSP1 stability that modulates phospholipid peroxidation and ferroptosis sensitivity in c...
23813
Vijay G. Sankaran @bloodgenes.bsky.social · 27/02/2026
🙏 🙏 @samhegde.bsky.social!! Fantastic talk at #KSHemato26 from @gaoteng.bsky.social on our recent advances in mitochondrial 🧬 lineage tracing! Please check out the preprint: www.biorxiv.org/content/10.6...
070
Reposted by Vijay G. Sankaran
Keystone Symposia @keystonesymposia.bsky.social · 24/02/2026
Join us in congratulating the award winners from the National Heart, Lung, and Blood Institute, @niaidnews.bsky.social, and the Keystone Symposia Future of Science Fund at #KSHemato26 in Keystone! 👏 #FutureofScience #hematopoiesis #bonemarrow @bloodgenes.bsky.social @beaudinlab.bsky.social
022
Vijay G. Sankaran @bloodgenes.bsky.social · 21/02/2026
Check out this fascinating MPRA in human hematopoietic cells from Satish Nandakumar, @tewhey.bsky.social, and team!! www.biorxiv.org/content/10.6...
0145
Reposted by Vijay G. Sankaran
New Scientist @newscientist.com · 20/02/2026
Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory infection RSV than existing antibody therapies, and are now being developed as preventative treatments
newscientist.com
Paediatricians’ blood used to make new treatments for RSV and colds
Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory infection RSV than existing antibody therapies, and are now being developed as preventative treatments
13421123
Reposted by Vijay G. Sankaran
Eric Topol @erictopol.bsky.social · 20/02/2026
The $100 whole human genome sequence finally reached! www.sandiegouniontribune.com/2026/02/19/s...
1125477
Vijay G. Sankaran @bloodgenes.bsky.social · 19/02/2026
Fascinating article by the insightful @jasonmast.bsky.social!! Maybe 🩸 stem cell expansion could help?: www.nature.com/articles/s41...
051
Vijay G. Sankaran @bloodgenes.bsky.social · 19/02/2026
Exciting clinical study in @nejm.org from Cherqui Lab @ucsdhealth.bsky.social showing how 🩸 stem cell 🧬 therapy can treat cystinosis, a lysosomal metabolic disorder! Expanding the scope of 🩸🧬 tx! www.nejm.org/doi/full/10....
052
Vijay G. Sankaran @bloodgenes.bsky.social · 18/02/2026
Fascinating paper in @nature.com today about how 🧬 variant impacting cyclin D3 alters malaria infectivity of red cells! www.nature.com/articles/s41..., www.nature.com/articles/d41... ... Follows up on some of our original studies from over 14 years ago: genesdev.cshlp.org/content/26/1...
070
Vijay G. Sankaran @bloodgenes.bsky.social · 15/02/2026
Check out this important advance in mitochondrial 🧬 lineage tracing by @gaoteng.bsky.social and @wengchen.bsky.social from our group, in collaboration with @jswlab.bsky.social 👇👇
0173
Reposted by Vijay G. Sankaran
Waggoner Lab @labwaggoner.bsky.social · 13/02/2026
@biorxivpreprint.bsky.social Modeling mitochondrial inheritance enables high-precision single-cell lineage tracing in humans www.biorxiv.org/content/10.6... @bloodgenes.bsky.social @jswlab.bsky.social @bostonchildrens.bsky.social @hhmi-science.bsky.social @broadinstitute.org
0175